849 related articles for article (PubMed ID: 15844659)
21. Peroxisome proliferator‑activated receptor γ agonist rosiglitazone inhibits migration and invasion of prostate cancer cells through inhibition of the CXCR4/CXCL12 axis.
Qin L; Gong C; Chen AM; Guo FJ; Xu F; Ren Y; Liao H
Mol Med Rep; 2014 Aug; 10(2):695-700. PubMed ID: 24842333
[TBL] [Abstract][Full Text] [Related]
22. The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma.
Hu J; Deng X; Bian X; Li G; Tong Y; Li Y; Wang Q; Xin R; He X; Zhou G; Xie P; Li Y; Wang JM; Cao Y
Clin Cancer Res; 2005 Jul; 11(13):4658-65. PubMed ID: 16000558
[TBL] [Abstract][Full Text] [Related]
23. The inflammatory cytokine tumor necrosis factor-alpha regulates chemokine receptor expression on ovarian cancer cells.
Kulbe H; Hagemann T; Szlosarek PW; Balkwill FR; Wilson JL
Cancer Res; 2005 Nov; 65(22):10355-62. PubMed ID: 16288025
[TBL] [Abstract][Full Text] [Related]
24. Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells.
Burger M; Glodek A; Hartmann T; Schmitt-Gräff A; Silberstein LE; Fujii N; Kipps TJ; Burger JA
Oncogene; 2003 Nov; 22(50):8093-101. PubMed ID: 14603250
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of CXCR4 expression in PC-3 cells by stromal-derived factor-1alpha (CXCL12) increases endothelial adhesion and transendothelial migration: role of MEK/ERK signaling pathway-dependent NF-kappaB activation.
Kukreja P; Abdel-Mageed AB; Mondal D; Liu K; Agrawal KC
Cancer Res; 2005 Nov; 65(21):9891-8. PubMed ID: 16267013
[TBL] [Abstract][Full Text] [Related]
26. CCR2 expression correlates with prostate cancer progression.
Lu Y; Cai Z; Xiao G; Liu Y; Keller ET; Yao Z; Zhang J
J Cell Biochem; 2007 Jun; 101(3):676-85. PubMed ID: 17216598
[TBL] [Abstract][Full Text] [Related]
27. [Effect of chemokine CXCL12 and its receptor CXCR4 on proliferation, migration and invasion of epithelial ovarian cancer cells].
Jiang YP; Wu XH; Xing HY; DU XY
Zhonghua Fu Chan Ke Za Zhi; 2007 Jun; 42(6):403-7. PubMed ID: 17697603
[TBL] [Abstract][Full Text] [Related]
28. CXCR4 chemokine receptor mediates prostate tumor cell adhesion through alpha5 and beta3 integrins.
Engl T; Relja B; Marian D; Blumenberg C; Müller I; Beecken WD; Jones J; Ringel EM; Bereiter-Hahn J; Jonas D; Blaheta RA
Neoplasia; 2006 Apr; 8(4):290-301. PubMed ID: 16756721
[TBL] [Abstract][Full Text] [Related]
29. Emodin inhibits invasion and migration of prostate and lung cancer cells by downregulating the expression of chemokine receptor CXCR4.
Ok S; Kim SM; Kim C; Nam D; Shim BS; Kim SH; Ahn KS; Choi SH; Ahn KS
Immunopharmacol Immunotoxicol; 2012 Oct; 34(5):768-78. PubMed ID: 22299827
[TBL] [Abstract][Full Text] [Related]
30. Chemokine receptor expression profiles in nasopharyngeal carcinoma and their association with metastasis and radiotherapy.
Ou DL; Chen CL; Lin SB; Hsu CH; Lin LI
J Pathol; 2006 Nov; 210(3):363-73. PubMed ID: 16955398
[TBL] [Abstract][Full Text] [Related]
31. [The role of stromal cell derived factor-1/CXCR4 biological axis in tumor metastasis of non-Hodgkin lymphoma].
Zhang C; Cui GH; Liu F; Wu QL; Chen Y
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(10):695-7. PubMed ID: 17553309
[TBL] [Abstract][Full Text] [Related]
32. Epithelial cancer cell migration: a role for chemokine receptors?
Scotton CJ; Wilson JL; Milliken D; Stamp G; Balkwill FR
Cancer Res; 2001 Jul; 61(13):4961-5. PubMed ID: 11431324
[TBL] [Abstract][Full Text] [Related]
33. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW
Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660
[TBL] [Abstract][Full Text] [Related]
34. SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis.
Uygur B; Wu WS
Mol Cancer; 2011 Nov; 10():139. PubMed ID: 22074556
[TBL] [Abstract][Full Text] [Related]
35. Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H; Mansel RE; Jiang WG
Int J Oncol; 2005 May; 26(5):1429-34. PubMed ID: 15809737
[TBL] [Abstract][Full Text] [Related]
36. CXC chemokine receptor CXCR4 expression enhances tumorigenesis and angiogenesis of basal cell carcinoma.
Chen GS; Yu HS; Lan CC; Chow KC; Lin TY; Kok LF; Lu MP; Liu CH; Wu MT
Br J Dermatol; 2006 May; 154(5):910-8. PubMed ID: 16634895
[TBL] [Abstract][Full Text] [Related]
37. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.
Lu Y; Wang J; Xu Y; Koch AE; Cai Z; Chen X; Galson DL; Taichman RS; Zhang J
Mol Cancer Res; 2008 Apr; 6(4):546-54. PubMed ID: 18344492
[TBL] [Abstract][Full Text] [Related]
38. Increased survival, proliferation, and migration in metastatic human pancreatic tumor cells expressing functional CXCR4.
Marchesi F; Monti P; Leone BE; Zerbi A; Vecchi A; Piemonti L; Mantovani A; Allavena P
Cancer Res; 2004 Nov; 64(22):8420-7. PubMed ID: 15548713
[TBL] [Abstract][Full Text] [Related]
39. Modulation of CXC-motif chemokine receptor 7, but not 4, expression is related to migration of the human prostate cancer cell LNCaP: regulation by androgen and inflammatory stimuli.
Yu L; Pham Q; Yu LL; Wang TTY
Inflamm Res; 2020 Feb; 69(2):167-178. PubMed ID: 31865399
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
